These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2335944)

  • 1. [Effect of Bonnecor on clinical manifestations, bioelectric cardiac activity and cardiac hemodynamics in patients with acute myocardial infarction and chronic ischemic heart disease].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Klin Med (Mosk); 1990 Feb; 68(2):44-6. PubMed ID: 2335944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of bonnecor in ischemic heart disease].
    Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
    Sov Med; 1990; (6):72-4. PubMed ID: 2396129
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of arrhythmias in chronic ischemic heart disease.
    Furukawa T; Myerburg RJ
    Cardiovasc Clin; 1992; 22(1):19-43. PubMed ID: 1728426
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
    Kaverina NV; Lyskovzev VV; Grigoreva JK; Senova ZP; Sulakvelidze MT; Grizenko AN
    Pharmazie; 1985 Dec; 40(12):845-7. PubMed ID: 3841599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of rhythm and conduction disorders in coronary atherosclerosis].
    Shopova VN
    Vrach Delo; 1972 Oct; 10():8-11. PubMed ID: 4658423
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute ischemic heart disease alters ventricular fibrillation waveform characteristics in out-of hospital cardiac arrest.
    Olasveengen TM; Eftestøl T; Gundersen K; Wik L; Sunde K
    Resuscitation; 2009 Apr; 80(4):412-7. PubMed ID: 19217199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of cardiac rhythm and conduction in acute myocardial infarct during the first 3 days and the effectiveness of their treatment].
    Kochlamazashvili AI
    Ter Arkh; 1975; 47(7):44-51. PubMed ID: 1224349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estimation of the P wave and PQ interval dispersion in patients after the myocardial infarction].
    Jołda-Mydłowska B; Kobusiak-Prokopowicz M; Negrusz-Kawecka M
    Pol Merkur Lekarski; 2005 Dec; 19(114):783-7. PubMed ID: 16521423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias associated with myocardial ischaemia and infarction.
    Botting JH; Curtis MJ; Walker MJ
    Mol Aspects Med; 1985; 8(4):307-422. PubMed ID: 3916014
    [No Abstract]   [Full Text] [Related]  

  • 19. Conduction abnormalities in the presence of acute myocardial infarction.
    Snipes JJ; Neal RW
    J Okla State Med Assoc; 1971 Apr; 64(4):141-7. PubMed ID: 5572849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of calcium antagonists].
    Klaus W
    Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.